Search

everythinglearnresearchcommunity

for

Search:↓

Pioglitazone, Trimipramine, and Dimetindene may be repurposed to treat psoriasis.

Rats developed lung issues from the drugs, but these cleared quickly after stopping them.

Cepharanthine, a Japanese hair loss drug, shows promise as a COVID-19 treatment but needs more testing.

Cutaneous lupus patients have higher levels of certain immune cells in their blood and skin.

Biological therapy boosts the immune system to effectively fight melanoma.

Newer retinoid drugs are effective for skin conditions but have significant side effects.

RU 58841 may treat acne, hair loss, and excessive hair growth.

A new method efficiently creates biaryl N-oxides with potential for cancer treatment and drug development.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

New cancer treatments are less harmful to hair but can still cause hair loss, color, shape, and growth changes.

The patient's symptoms improved with treatment but recurred when the steroid dose was reduced, requiring ongoing therapy.

Mitotane changes steroid breakdown, affecting cortisol availability.

Temporary hair loss can occur after 5-fluorouracil treatment for keloids.

Sonidegib and vismodegib are similarly effective for advanced basal cell carcinoma, but sonidegib might have a slightly better safety profile.

HHV-6 reactivation may be linked to psychiatric disorders and can improve with antiviral treatment.

YH0618 helps reduce chemotherapy-induced hair loss by targeting specific proteins and pathways.

Tyrosine kinase inhibitors for endocrine tumors often cause skin issues, requiring early management and treatment adjustments.

We need safe, affordable drugs to fight coronaviruses effectively.

DPCP treatment for alopecia areata can sometimes cause vitiligo.

New butyric acid prodrugs show promise for cancer treatment, anemia management, and protecting hair from chemotherapy damage.

Certain natural compounds can block an enzyme linked to prostate enlargement and hair loss, showing potential for new treatments.

UV radiation may cause DNA changes in skin, certain UVB therapy helps psoriasis, a new gene mutation is linked to mild piebaldism, different immune cells affect psoriasis, a drug promotes hair growth, and some cancer drugs could treat skin barrier issues.

Topical calcitriol was safe and well-tolerated for potential hair loss prevention in chemotherapy patients.

Increasing ABC transporters in hair follicles may prevent chemotherapy-induced hair loss.

Many drugs, not just chemotherapy, can cause reversible hair loss.

Tacrolimus is an effective treatment for several skin conditions with fewer side effects than cyclosporine.

Oral JAK inhibitors improved alopecia areata by modulating immune responses and boosting hair growth.

Combining flutamide and finasteride can reduce prostate weight and tumor growth, potentially benefiting treatments needing optimal DHT inhibition.

Four new compounds were more effective than finasteride in treating prostate issues and hair loss, with one being 100 times more active and safe for use.

Some gonadal hormone drugs can block filovirus entry into cells.